Trials / Completed
CompletedNCT00970554
Effectiveness of Telescopic Magnification in the Treatment of Amblyopia
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- The Hospital for Sick Children · Academic / Other
- Sex
- All
- Age
- 4 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Amblyopia is a visual impairment of one eye that results from disuse of that eye during early brain development. The standard treatment for amblyopia consists of patching or pharmacological penalization of the sound eye. Unfortunately, approximately 50% of amblyopic children do not respond to these therapies, with poor compliance being a major factor in treatment failure. One new treatment strategy involves patching the sound eye while using a telescopic device on the amblyopic eye to magnify the images formed in the amblyopic eye. Children were randomized to receive either daily patching of the sound eye for 30 minutes only (patching only group), or daily patching of the sound eye for 30 minutes plus simultaneous use of a telescopic device by the amblyopic eye during patching (patching plus telescope group).
Detailed description
The goal of the present investigation was to conduct a prospective randomized clinical study to further evaluate the effectiveness of telescopic magnification plus patching vs patching alone on different types of amblyopia in patients who had failed previous treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patching | Patching of the sound eye for 30 minutes a day for 17 weeks. |
| OTHER | Telescopic magnification | Patching of the sound eye plus simultaneous use of a telescopic device by the amblyopic eye for 30 minutes a day for 17 weeks. |
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2009-09-02
- Last updated
- 2013-08-27
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00970554. Inclusion in this directory is not an endorsement.